Stockscreener 앱 받기
10.77
0.00%
0.00
시간 외 거래:
10.77
Helix Acquisition Corp Ii 주식(HLXB)의 최신 뉴스
Harraden Circle Investments LLC Takes Position in Helix Acquisition Corp. II (NASDAQ:HLXB) - MarketBeat
MLTX stock touches 52-week low at $36.51 amid market shifts - Investing.com Australia
MLTX stock touches 52-week low at $36.51 amid market shifts By Investing.com - Investing.com South Africa
BBOT Announces First Patient Dosed with BBO-11818, a PanKRAS Dual Inhibitor in the Phase 1 KONQUER-101 Trial for Advanced Solid Tumors - Business Wire
Firm foundations: Can US IPO markets continue to build on solid gains? - Lexology
Decagon Asset Management LLP Invests $1.96 Million in Helix Acquisition Corp. II (NASDAQ:HLXB) - MarketBeat
Newsroom - White & Case LLP
GSK’s $1.15B Idrx buyout leads slow M&A market as deals stay strong - BioWorld Online
Bay Area VC-funded life sciences companies raised over $5 billion in 2024 - The Business Journals
Helix Exploration expands with key acquisition at Rudyard - Proactive Investors
Helix Acquisition Corp. II SEC 10-K Report - TradingView
MLTX stock touches 52-week low at $37.53 amid market shifts - Investing.com Australia
BBIOBridgebio Pharma Latest Stock News & Market Updates - StockTitan
Helix Acquisition Corp. II’s US$949 Million Business Combination with BridgeBio Oncology Therapeutics - Global Legal Chronicle
BridgeBio Oncology and Helix enter definitive merger agreement - MSN
BridgeBio spin-out in SPAC deal to target RAS and PI3Kα malignancies - The Pharma Letter
White & Case advises Helix Acquisition Corp. II on its US$949 million business combination with BridgeBio Oncology Therapeutics - White & Case LLP
Helix Acquisition Corp. II (HLXB) to Combine with BridgeBio Oncology in $360M Deal - SPACInsider
Helix Acquisition Corp. II Merger with BridgeBio Oncology Therapeutics - Leerink Partners
Helix Acquisition Corp. II PIPE - Leerink Partners
Finance Watch: BridgeBio’s Oncology Spinout Reveals Go-Public Plan - insights.citeline.com
LZ Technology Closes $7.2 Million IPO -February 28, 2025 at 04:48 pm EST - Marketscreener.com
BridgeBio spinout to go public in SPAC deal with Helix Acquisition Corp. II - MSN
BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs - MedCity News
Boston SPAC picks biotech to take public - The Business Journals
Goodwin, White & Case Build BridgeBio's $949M SPAC Deal - Law360
BridgeBio oncology spinout to go public in blank-check merger - BioPharma Dive
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal - BioSpace
Helix Acquisition to Merge With BridgeBio Oncology Therapeutics - MarketScreener
BridgeBio's KRAS-focused cancer spinout backs SPAC as path to Nasdaq - Fierce Biotech
BridgeBio Oncology Therapeutics and Helix Acquisition Corp. II To Merge - citybiz
BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen - Endpoints News
$450M Deal Powers New Cancer-Fighting Biotech: What's Inside BridgeBio's Oncology SPAC Merger? - StockTitan
BridgeBio Pharma's cancer-focused spinout plans $450 million deal to go public - The Business Journals
Fifth Era Acquisition Corp. I (FERAU) Prices $200M IPO - SPACInsider
NewHold Investment Corp. III (NHICU) Prices $175M IPO - SPACInsider
Live Oak Acquisition Corp. V (LOKVU) Prices $200M IPO - SPAC Insider
Wall Street Sentiment Positive After Nvidia Earnings, Lifting US Equity Futures Pre-Bell - Marketscreener.com
Rithm Acquisition Corp. (RAC.U) Prices $200M IPO - SPAC Insider
Helix Acquisition Corp. II appoints new independent director - MSN
Blank Check Co Sichuan Hongyi Enterprise Management Co Ltd Files For IPO Of Up To $100 Mln - Marketscreener.com
Podcast: Inside the Private Markets with Nick Fusco, Founder & CEO of PM Insights - SPAC Insider
EQT has sold Waystar shares for $ 393 million -February 25, 2025 at 12:34 am EST - Marketscreener.com
10 Oversold Pharma Stocks to Buy According to Analysts - Insider Monkey
KKR plans $2 billion sale of BMC Helix - Traders Union
Investors Await Business Activity, Home Sales Data as US Equity Futures Point to Mixed Open for Wall Street - Marketscreener.com
Wellgistics Health Prices $4 Million IPO -February 21, 2025 at 08:26 am EST - Marketscreener.com
Hyzon Motors Plans to Delist From Nasdaq -February 21, 2025 at 03:50 am EST - Marketscreener.com
KKR Prepares Sale of BMC Helix at $2 Billion Value - Bloomberg.com
BridgeBio: Strong Start For Attruby (NASDAQ:BBIO) - Seeking Alpha
12 Most Oversold Healthcare Stocks to Buy Now - Insider Monkey
Stocks Down Pre-Bell Ahead of Latest Retail Sales Report; Asia, Europe Mostly Up -February 14, 2025 at 07:12 am EST - Marketscreener.com
BridgeBio Earnings Preview: First Attruby Sales Data and Clinical Pipeline Milestones Ahead - StockTitan
Robot Consulting Files For US IPO -February 12, 2025 at 05:45 pm EST - Marketscreener.com
Helix Acquisition Corp. II Appoints Albert A. Holman, III to Board of Directors - Defense World
0.53%
0.00%
자본화:
|
볼륨(24시간):